HAE Haemonetics Corporation Common Stock
$107.00
가격 · 8월 19, 2026
기준 재무 정보 8월 6, 2026
Haemonetics Corporation Common Stock 정보 위키백과 회사 개요
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
더 보기
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas.
History
The company was founded in 1971. Haemonetics started out producing the containers and bags required for blood collection. The Latham Bowl was a disposable container that could automate the separation of blood by centrifugation. Through the 90's, the company added additional product lines and technologies. The company opened a manufacturing facility in Holbrook, Massachusetts in 1988.
In 1995 the company purchased the Intravenous Solutions manufacturing facility in Union, South Carolina.
Additional acquisitions grew the company and expanded its services. In the following years the company branched off to making the whole plasma collection station including the machine, supplies and software for plasma collection. These acquisitions included Edmonton-based Fifth Dimension (5D) Information Systems to gain entry into the blood and plasma software industry. Further acquisitions include Chicago-based Arryx in July 2006, Information Data Management, Inc. in January 2007, the acquisition of a division of Haemoscope in 2007, the acquisition of Infonale in July 2007, and, in 2009, Chico, California-based Altivation and Tucson, Arizona-based Sebra.
On August 21, 2007, 5D and IDM were officially merged into a new subsidiary called Haemonetics Software Solutions. The employees at both Edmonton (5D) and Rosemont (IDM) continue to work from their respective offices.
Further acquisitions included the April 2009 acquisition of Neoteric Technology Ltd and the April 2010 acquisition of California-based Global Med Technologies, Inc. Haemonetics acquired the Pall Corporation's transfusion medicine business on August 1, 2012 for ~$550 million.
In April 2024, it was announced Haemonetics had completed its acquisition of the Chicago-headquartered medical device temperature regulation manufacturer, Attune Medical for $160 million.
Product categories
Haemonetics products can be considered as belonging to two broad categories. Donor products (marketed to the blood donation industry, these include products that automate the blood donation process, automate the processing of blood, support pathogen inactivation and bacterial detection of blood, and test blood hematocrit); and products that are marketed to the surgical suite for blood loss management for patients. These products include surgical blood salvage (or "autotransfusion") devices, surgical field blood suction systems, and blood and patient warming systems.
Hemostasis
TEG 5000
Kaolin TEG
Kaolin TEG with Heparinase
RapidTEG
TEG Functional Fibrinogen
TEG PlateletMapping
TEG 6S
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
HAE 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$107.00
시가총액
$4.84B
P/E (TTM)
52.2
EPS (TTM)
$2.05
매출 (TTM)
$1.33B
배당 수익률
—
ROE
11.8%
부채/자본
1.5
52주 범위
$47 – $107
HAE 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$1.33B
2017-04-01
→
2026-03-28
EPS
$2.05
2017-04-01
→
2026-03-28
잉여현금흐름
$260M
2017-04-01
→
2026-03-28
마진
7.3%
2017-04-01
→
2026-03-28
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
HAE
동종업계 중앙값
P/E (TTM)
52.2
39.4
P/S (TTM)
3.6
2.1
P/B
6.1
3.3
EV / EBITDA
37.1
—
Price / FCF (주가 / FCF)
18.6
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
HAE
동종업계 중앙값
Gross Margin (매출 총이익률)
59.0%
58.7%
Operating Margin (영업이익률)
11.8%
—
Net Profit Margin (순이익률)
7.3%
-11.8%
ROA
4.0%
-6.3%
ROE
11.8%
-13.4%
ROIC
5.9%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
HAE
동종업계 중앙값
Debt / Equity (부채 / 자기자본 비율)
1.5
37.4
Current Ratio (유동비율)
3.0
2.4
Quick Ratio (당좌 비율)
1.6
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
HAE
동종업계 중앙값
Revenue YoY (매출 YoY)
-2.0%
—
Revenue CAGR 3Y (매출 CAGR 3년)
4.5%
—
Revenue CAGR 5Y (매출 CAGR 5년)
8.9%
—
EPS YoY
-38.1%
—
Net Income YoY (순이익 YoY)
-42.0%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
HAE
동종업계 중앙값
HAE 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
15 명의 애널리스트
- 적극 매수 5 33.3%
- 매수 6 40.0%
- 보유 4 26.7%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
10 명의 애널리스트 · 2026-08-13
중앙값
$95.50
모든 목표가 상회 →
$107.00
저가
$86.00
고가
$105.00
중앙값 목표
$95.50
-10.7%
평균 목표
$96.20
-10.1%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
0.06%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2027년 3월 31일 | $1.14 | $1.09 | 0.05% |
| 2026년 6월 30일 | $1.14 | $1.09 | 0.05% |
| 2026년 3월 31일 | $1.29 | $1.28 | 0.01% |
| 2025년 12월 31일 | $1.31 | $1.26 | 0.05% |
| 2025년 9월 30일 | $1.27 | $1.12 | 0.15% |
| 2025년 6월 30일 | $1.10 | $1.03 | 0.07% |
| 2025년 3월 31일 | $1.24 | $1.23 | 0.01% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| COO | $13.70B | 37.4 | 5.1% | 9.2% | 4.6% | 65.5% |
| ALGN | $11.14B | 27.6 | 0.90% | 10.2% | 10.3% | 67.2% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | — |
| XRAY | $2.28B | -3.8 | -3.0% | -16.2% | -36.4% | 50.0% |
| NEOG | $1.95B | -224.2 | -2.7% | -0.91% | -0.38% | 46.9% |
| UFPT | $1.71B | 25.4 | 19.5% | 11.3% | 16.9% | 28.3% |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 16
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.33B | $1.36B | $1.31B | $1.17B | $993M | $870M | $988M | $968M | $904M | $886M | $909M | $910M | |
| Cost of Revenue | $546M | $612M | $618M | $554M | $488M | $473M | $504M | $550M | $492M | $508M | $503M | $476M | |
| Gross Profit | $788M | $749M | $692M | $615M | $506M | $398M | $485M | $418M | $412M | $378M | $406M | $434M | |
| R&D Expense | $60M | $63M | $54M | $50M | $47M | $33M | $31M | $36M | $39M | $38M | $45M | $54M | |
| SG&A Expense | $442M | $437M | $430M | $377M | $340M | $275M | $282M | $273M | $317M | $302M | $317M | $337M | |
| Operating Expenses | $631M | $527M | $527M | $459M | $425M | $308M | $381M | $334M | $356M | $398M | $450M | $394M | |
| Operating Income | $157M | $222M | $165M | $156M | $81M | $90M | $103M | $84M | $56M | $-19M | $-44M | $41M | |
| Other Non-op | $-29M | $-10M | $-13M | $-15M | $-17M | $-17M | $-16M | $-10M | $-5M | $-8M | $-9M | $-9M | |
| Pretax Income | $128M | $212M | $152M | $141M | $64M | $73M | $87M | $74M | $60M | $-27M | $-53M | $31M | |
| Income Tax | $31M | $44M | $34M | $26M | $20M | $-7M | $11M | $19M | $14M | $-1M | $2M | $14M | |
| Net Income | $97M | $168M | $118M | $115M | $43M | $79M | $77M | $55M | $46M | $-26M | $-56M | $17M | |
| EPS (Basic) | $2.06 | $3.33 | $2.32 | $2.27 | $0.85 | $1.57 | $1.51 | $1.07 | $0.86 | $-0.51 | $-1.09 | $0.33 | |
| EPS (Diluted) | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 | $1.55 | $1.48 | $1.04 | $0.85 | $-0.51 | $-1.09 | $0.32 | |
| Shares (Basic) | 47,179,000 | 50,330,000 | 50,706,000 | 50,783,000 | 51,047,000 | 50,688,000 | 50,692,000 | 51,533,000 | 52,755,000 | 51,524,000 | 50,910,000 | 51,533,000 | |
| Shares (Diluted) | 47,354,000 | 50,730,000 | 51,397,000 | 51,420,000 | 51,353,000 | 51,292,000 | 51,815,000 | 52,942,000 | 53,501,000 | 51,524,000 | 50,910,000 | 52,089,000 | |
| EBITDA | $157M | $222M | $165M | $156M | $81M | $90M | $103M | $84M | $56M | $-19M | $-44M | $41M |
대차대조표 25
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $245M | $307M | $179M | $284M | $259M | $192M | $137M | $169M | $180M | $140M | $115M | $161M | |
| Receivables | $217M | $203M | $207M | $179M | $159M | $128M | $165M | $185M | $151M | $153M | $157M | $146M | |
| Inventory | $306M | $365M | $317M | $259M | $293M | $323M | $270M | $194M | $161M | $177M | $187M | $211M | |
| Prepaid Expense | $66M | $60M | $66M | $47M | $44M | $51M | $31M | $27M | $29M | $41M | $29M | $40M | |
| Current Assets | $835M | $935M | $769M | $770M | $756M | $694M | $604M | $576M | $521M | $510M | $488M | $558M | |
| PP&E (Net) | $306M | $284M | $311M | $311M | $258M | $218M | $253M | $344M | $332M | $324M | $338M | $322M | |
| PP&E (Gross) | $842M | $837M | $959M | $944M | $869M | $817M | $832M | $933M | $873M | $807M | $786M | $732M | |
| Accum. Depreciation | $536M | $553M | $648M | $633M | $611M | $600M | $579M | $589M | $541M | $484M | $449M | $410M | |
| Goodwill | $656M | $604M | $565M | $466M | $467M | $466M | $211M | $211M | $211M | $211M | $268M | $334M | |
| Intangibles | $448M | $456M | $406M | $276M | $310M | $365M | $133M | $128M | $157M | $178M | $204M | $245M | |
| Other Non-current Assets | $142M | $164M | $136M | $107M | $63M | $71M | $62M | $12M | $12M | $12M | $14M | $11M | |
| Total Assets | $2.40B | $2.45B | $2.20B | $1.93B | $1.86B | $1.82B | $1.27B | $1.27B | $1.24B | $1.24B | $1.32B | $1.49B | |
| Accounts Payable | $51M | $67M | $73M | $64M | $58M | $50M | $51M | $63M | $55M | $43M | $40M | $48M | |
| Current Liabilities | $283M | $578M | $300M | $252M | $442M | $253M | $275M | $236M | $385M | $211M | $186M | $189M | |
| Capital Leases | $41M | $50M | $58M | $56M | $56M | $63M | $52M | · | · | · | · | · | |
| Deferred Tax | $38M | $63M | $63M | $36M | $29M | $44M | $11M | $20M | $7M | $12M | $21M | $33M | |
| Other Non-current Liabilities | $59M | $68M | $75M | $75M | $80M | $100M | $89M | $29M | $34M | $22M | $26M | $32M | |
| Long-term Debt | $1.24B | $1.22B | $808M | $766M | $774M | $708M | $382M | $350M | $254M | $316M | $408M | $430M | |
| Total Debt | $1.22B | $1.22B | $808M | $766M | $774M | $708M | $382M | $350M | $254M | $315M | $408M | $428M | |
| Common Stock | $453.0K | $482.0K | $508.0K | $504.0K | $511.0K | $509.0K | $503.0K | $510.0K | $523.0K | $523.0K | $509.0K | $517.0K | |
| Retained Earnings | $279M | $352M | $360M | $253M | $202M | $158M | $79M | $161M | $267M | $290M | $316M | $420M | |
| AOCI | $-38M | $-55M | $-36M | $-30M | $-26M | $-30M | $-45M | $-30M | $-19M | $-33M | $-35M | $-22M | |
| Stockholders' Equity | $796M | $821M | $960M | $818M | $749M | $732M | $587M | $668M | $752M | $740M | $722M | $826M | |
| Liabilities + Equity | $2.40B | $2.45B | $2.20B | $1.93B | $1.86B | $1.82B | $1.27B | $1.27B | $1.24B | $1.24B | $1.32B | $1.49B | |
| Shares Outstanding | 45,252,667 | 48,215,899 | 50,787,859 | 50,448,519 | 51,124,240 | 50,868,820 | 50,322,930 | 51,019,918 | 52,342,965 | 52,255,495 | 50,932,348 | 51,670,969 |
현금 흐름 16
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $112M | $116M | $97M | $93M | $98M | $84M | $110M | $109M | $89M | $90M | $90M | $86M | |
| Stock-based Comp | $34M | $30M | $28M | $26M | $24M | $26M | $20M | $17M | $13M | $9M | $7M | $14M | |
| Deferred Tax | $-26M | $-6M | $-11M | $6M | $5M | $-21M | $-7M | $13M | $-6M | $-7M | $-1M | $4M | |
| Amort. of Intangibles | $50M | $56M | $41M | $42M | $57M | $41M | $34M | $25M | $32M | $37M | $59M | $34M | |
| Restructuring | $3M | $14M | $14M | $657.0K | $4M | $1M | $4M | $395.0K | $31M | $22M | $23M | $37M | |
| Operating Cash Flow | $293M | $182M | $182M | $273M | $172M | $109M | $158M | $159M | $220M | $160M | $122M | $127M | |
| CapEx | $33M | $39M | $38M | $191M | $97M | $37M | $49M | $119M | $75M | $76M | $102M | $122M | |
| Investing Cash Flow | $-180M | $-162M | $-322M | $-144M | $-86M | $-425M | $-57M | $-116M | $-63M | $-73M | $-105M | $-122M | |
| Debt Issued | · | · | · | · | · | · | $0 | $348M | $0 | $0 | · | $0 | |
| Net Debt Issued | · | $-5M | $-12M | $-10M | $-18M | $-22M | $-13M | $81M | $-62M | $-43M | $-21M | $-9M | |
| Stock Repurchased | $175M | $225M | $0 | $75M | $0 | $0 | $175M | $160M | $100M | $0 | $61M | $39M | |
| Net Stock Activity | $-175M | $-225M | $0 | $-75M | $0 | $0 | $-175M | $-160M | $-100M | $0 | $-61M | $-39M | |
| Financing Cash Flow | $-178M | $109M | $38M | $-100M | $-16M | $367M | $-131M | $-51M | $-121M | $-60M | $-63M | $-33M | |
| Net Change in Cash | $-61M | $128M | $-106M | $25M | $67M | $55M | $-32M | $-11M | $41M | $24M | $-46M | $-32M | |
| Taxes Paid | $61M | · | · | · | · | $12M | $12M | $8M | $9M | $7M | $8M | $11M | |
| Free Cash Flow | $260M | $142M | $115M | $163M | $76M | $72M | $109M | $40M | $146M | $84M | $19M | $5M |
수익성 8
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.0% | 55.0% | 52.8% | 52.6% | 50.9% | 45.7% | 49.0% | 43.1% | 45.6% | 42.7% | 44.7% | 47.7% | |
| Operating Margin | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% | 10.3% | 10.5% | 8.6% | 6.2% | -2.2% | -4.8% | 4.5% | |
| Net Margin | 7.3% | 12.3% | 9.0% | 9.9% | 4.4% | 9.1% | 7.7% | 5.7% | 5.0% | -3.0% | -6.1% | 1.9% | |
| Pretax Margin | 9.6% | 15.6% | 11.6% | 12.1% | 6.4% | 8.4% | 8.8% | 7.6% | 6.6% | -3.1% | -5.9% | 3.4% | |
| EBITDA Margin | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% | 10.3% | 10.5% | 8.6% | 6.2% | -2.2% | -4.8% | 4.5% | |
| ROA | 4.0% | 7.2% | 5.7% | 6.1% | 2.4% | 5.1% | 6.0% | 4.4% | 3.7% | -2.1% | -4.0% | 1.1% | |
| ROE | 11.8% | 19.4% | 12.3% | 14.5% | 5.9% | 11.0% | 13.2% | 8.7% | 6.1% | -3.6% | -7.2% | 2.0% | |
| ROIC | 5.9% | 8.6% | 7.2% | 8.0% | 3.6% | 6.8% | 9.4% | 6.1% | 4.3% | -1.8% | -4.0% | 1.8% |
유동성 및 지급능력 4
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 1.6 | 2.6 | 3.1 | 1.7 | 2.7 | 2.2 | 2.4 | 1.4 | 2.4 | 2.6 | 3.0 | |
| Quick Ratio | 1.6 | 0.9 | 1.3 | 1.8 | 0.9 | 1.3 | 1.1 | 1.5 | 0.9 | 1.4 | 1.5 | 1.6 | |
| Debt / Equity | 1.5 | 1.5 | 0.8 | 0.9 | 1.0 | 1.0 | 0.7 | 0.5 | 0.3 | 0.4 | 0.6 | 0.5 | |
| LT Debt / Equity | 1.5 | 1.1 | 0.8 | 0.9 | 0.7 | 0.9 | 0.5 | 0.5 | 0.1 | 0.3 | 0.5 | 0.5 |
효율성 3
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.8 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | |
| Inventory Turnover | 1.6 | 1.8 | 2.1 | 2.0 | 1.6 | 1.6 | 2.2 | 3.1 | 2.9 | 2.8 | 2.5 | 2.3 | |
| Receivables Turnover | 6.4 | 6.7 | 6.8 | 6.9 | 6.9 | 5.9 | 5.6 | 5.8 | 5.9 | 5.7 | 6.0 | 5.9 |
성장률 9
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -2.0% | 4.0% | 12.0% | 17.7% | 14.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 4.5% | 11.1% | 14.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -38.1% | 44.5% | 2.2% | 166.7% | -45.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -2.9% | 58.0% | 13.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 5.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -42.0% | 42.6% | 1.9% | 166.1% | -45.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -5.5% | 56.9% | 13.9% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 4.1% | · | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 14
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.33B | $1.36B | $1.31B | $1.17B | $993M | $870M | $988M | $968M | $904M | $886M | $909M | $910M | |
| Net Income TTM | $97M | $168M | $118M | $115M | $43M | $79M | $77M | $55M | $46M | $-26M | $-56M | $17M | |
| Market Cap | $2.45B | $3.05B | $4.33B | $4.17B | $3.26B | $5.70B | $5.08B | $4.46B | $3.83B | $2.12B | $1.80B | $2.28B | |
| Enterprise Value | $3.42B | $3.96B | $4.96B | $4.66B | $3.78B | $6.21B | $5.33B | $4.64B | $3.90B | $2.30B | $2.09B | $2.55B | |
| P/E | 26.4 | 19.1 | 37.3 | 36.9 | 76.0 | 72.3 | 68.2 | 84.1 | 86.1 | -79.5 | -32.4 | 138.2 | |
| P/S | 1.8 | 2.2 | 3.3 | 3.6 | 3.3 | 6.5 | 5.1 | 4.6 | 4.2 | 2.4 | 2.0 | 2.5 | |
| P/B | 3.1 | 3.7 | 4.5 | 5.1 | 4.4 | 7.8 | 8.7 | 6.7 | 5.1 | 2.9 | 2.5 | 2.8 | |
| P / Tangible Book | · | · | · | 54.9 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 8.3 | 16.8 | 23.8 | 15.3 | 18.9 | 52.4 | 32.1 | 28.0 | 17.4 | 13.3 | 14.7 | 18.0 | |
| P / FCF | 9.4 | 21.4 | 37.5 | 25.6 | 43.1 | 79.4 | 46.4 | 110.7 | 26.3 | 25.4 | 92.4 | 460.7 | |
| EV / EBITDA | 21.8 | 17.9 | 30.1 | 29.8 | 46.8 | 69.2 | 51.5 | 55.6 | 69.5 | -118.4 | -47.6 | 62.9 | |
| EV / FCF | 13.1 | 27.8 | 43.0 | 28.6 | 49.9 | 86.6 | 48.7 | 115.2 | 26.8 | 27.5 | 107.4 | 514.6 | |
| EV / Revenue | 2.6 | 2.9 | 3.8 | 4.0 | 3.8 | 7.1 | 5.4 | 4.8 | 4.3 | 2.6 | 2.3 | 2.8 | |
| Earnings Yield | 3.8% | 5.2% | 2.7% | 2.7% | 1.3% | 1.4% | 1.5% | 1.2% | 1.2% | -1.3% | -3.1% | 0.72% |
손익계산서 16
| 지표 | 추세 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $339M | $346M | $339M | $327M | $321M | $331M | $349M | $346M | $336M | $343M | $336M | $318M | $340M | $305M | $297M | |
| Cost of Revenue | $137M | $148M | $137M | $133M | $129M | $138M | $155M | $158M | $161M | $167M | $158M | $148M | $169M | $147M | $140M | |
| Gross Profit | $203M | $198M | $202M | $195M | $192M | $193M | $194M | $187M | $175M | $176M | $178M | $171M | $172M | $159M | $158M | |
| R&D Expense | $16M | $14M | $14M | $15M | $16M | $18M | $16M | $14M | $14M | $16M | $13M | $13M | $16M | $13M | $11M | |
| SG&A Expense | $119M | $121M | $109M | $102M | $111M | $115M | $106M | $107M | $108M | $109M | $112M | $115M | $98M | $95M | $92M | |
| Operating Expenses | $145M | $221M | $135M | $136M | $138M | $122M | $135M | $136M | $135M | $146M | $132M | $135M | $121M | $115M | $111M | |
| Operating Income | $57M | $-23M | $67M | $58M | $54M | $71M | $59M | $52M | $40M | $30M | $46M | $35M | $51M | $43M | $47M | |
| Other Non-op | $-10M | $-5M | $-7M | $-7M | $-9M | $-598.0K | $-9M | $-7M | $7M | $-7M | $-2M | $-2M | $-3M | $-1M | $-6M | |
| Pretax Income | $48M | $-28M | $60M | $51M | $45M | $71M | $50M | $45M | $47M | $23M | $44M | $33M | $48M | $42M | $41M | |
| Income Tax | $15M | $-8M | $15M | $13M | $11M | $13M | $12M | $11M | $8M | $3M | $13M | $8M | $5M | $9M | $8M | |
| Net Income | $33M | $-20M | $45M | $39M | $34M | $58M | $37M | $34M | $38M | $20M | $31M | $25M | $42M | $33M | $33M | |
| EPS (Basic) | $0.73 | $-0.42 | $0.96 | $0.81 | $0.71 | $1.17 | $0.75 | $0.66 | $0.75 | $0.40 | $0.62 | $0.49 | $0.84 | $0.65 | $0.65 | |
| EPS (Diluted) | $0.72 | $-0.41 | $0.95 | $0.81 | $0.70 | $1.17 | $0.74 | $0.66 | $0.74 | $0.40 | $0.61 | $0.48 | $0.84 | $0.64 | $0.64 | |
| Shares (Basic) | 45,361,000 | -95,314,000 | 46,792,000 | 47,590,000 | 48,111,000 | -101,797,000 | 50,286,000 | 50,898,000 | 50,943,000 | 27,000 | 50,768,000 | 50,727,000 | -102,174,000 | 50,509,000 | 50,953,000 | |
| Shares (Diluted) | 45,704,000 | -95,650,000 | 46,987,000 | 47,664,000 | 48,353,000 | -102,713,000 | 50,639,000 | 51,240,000 | 51,564,000 | 3,000 | 51,445,000 | 51,396,000 | -103,165,000 | 51,219,000 | 51,558,000 | |
| EBITDA | $57M | · | $67M | $58M | $54M | · | $59M | $52M | $40M | · | $46M | $35M | · | $43M | $47M |
대차대조표 25
| 지표 | 추세 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $223M | $245M | $363M | $296M | $293M | $307M | $321M | $299M | $344M | $179M | $194M | $351M | · | $224M | $241M | |
| Receivables | $216M | $217M | $196M | $207M | $201M | $203M | $212M | $214M | $201M | $207M | $212M | $174M | · | $181M | $172M | |
| Inventory | $307M | $306M | $321M | $336M | $361M | $365M | $360M | $382M | $374M | $317M | $304M | $286M | · | $256M | $255M | |
| Prepaid Expense | $65M | $66M | $63M | $60M | $59M | $60M | $113M | $61M | $59M | $66M | $55M | $55M | · | $45M | $48M | |
| Current Assets | $811M | $835M | $944M | $900M | $913M | $935M | $1.01B | $956M | $979M | $769M | $765M | $866M | · | $706M | $716M | |
| PP&E (Net) | $304M | $306M | $297M | $292M | $287M | $284M | $286M | $300M | $302M | $311M | $319M | $308M | · | $313M | $308M | |
| PP&E (Gross) | $854M | $842M | $837M | $815M | $795M | $837M | $867M | $939M | $949M | $959M | $979M | $950M | · | · | · | |
| Accum. Depreciation | $550M | $536M | $540M | $523M | $508M | $553M | $581M | $639M | $647M | $648M | $661M | $642M | · | · | · | |
| Goodwill | $657M | $656M | $607M | $606M | $607M | $604M | $605M | $616M | $613M | $565M | $555M | $465M | $466M | $466M | $465M | |
| Intangibles | $435M | $448M | $420M | $428M | $451M | $456M | $466M | $488M | $495M | $406M | $429M | $251M | · | $284M | $293M | |
| Other Non-current Assets | $150M | $142M | $216M | $208M | $196M | $164M | $160M | $156M | $142M | $136M | $127M | $117M | · | $103M | $80M | |
| Total Assets | $2.37B | $2.40B | $2.49B | $2.44B | $2.46B | $2.45B | $2.53B | $2.53B | $2.54B | $2.20B | $2.20B | $2.01B | · | $1.88B | $1.87B | |
| Accounts Payable | $56M | $51M | $49M | $62M | $46M | $67M | $63M | $69M | $77M | $73M | $57M | $80M | · | $64M | $61M | |
| Current Liabilities | $263M | $283M | $540M | $548M | $531M | $578M | $253M | $274M | $260M | $300M | $262M | $264M | · | $227M | $262M | |
| Capital Leases | · | $41M | · | · | · | $50M | · | · | · | $58M | · | · | · | · | · | |
| Deferred Tax | $39M | $38M | $56M | $58M | $59M | $63M | $61M | $63M | $65M | $63M | $62M | $35M | · | $40M | $36M | |
| Other Non-current Liabilities | $57M | $59M | $64M | $66M | $68M | $68M | $90M | $90M | $92M | $75M | $76M | $70M | · | $78M | $78M | |
| Long-term Debt | $1.19B | $1.24B | $1.22B | $1.22B | $1.22B | $1.25B | $1.22B | $1.22B | $1.22B | $808M | $871M | $762M | · | $767M | $818M | |
| Total Debt | $1.17B | · | $1.22B | $1.22B | $1.22B | · | $1.22B | $1.22B | $1.22B | · | $871M | $762M | · | $767M | $818M | |
| Common Stock | $455.0K | $453.0K | $468.0K | $467.0K | $482.0K | $482.0K | $502.0K | $504.0K | $512.0K | $508.0K | $508.0K | $507.0K | · | $504.0K | $506.0K | |
| Retained Earnings | $312M | $279M | $381M | $336M | $356M | $352M | $392M | $369M | $387M | $360M | $340M | $309M | · | $224M | $204M | |
| AOCI | $-42M | $-38M | $-35M | $-41M | $-36M | $-55M | $-56M | $-35M | $-43M | $-36M | $-24M | $-33M | · | $-36M | $-40M | |
| Stockholders' Equity | $837M | $796M | $911M | $849M | $882M | $821M | $907M | $879M | $905M | $960M | $943M | $894M | $818M | $776M | $729M | |
| Liabilities + Equity | $2.37B | $2.40B | $2.49B | $2.44B | $2.46B | $2.45B | $2.53B | $2.53B | $2.54B | $2.20B | $2.20B | $2.01B | · | $1.88B | $1.87B | |
| Shares Outstanding | 45,471,313 | 45,252,667 | 46,829,249 | 46,747,381 | 48,158,723 | 48,215,899 | 50,235,051 | 50,381,127 | 51,152,886 | 50,787,859 | 50,785,040 | 50,740,389 | · | 50,444,470 | 50,605,499 |
현금 흐름 13
| 지표 | 추세 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $27M | $27M | $27M | $28M | $29M | $28M | $29M | $29M | $29M | $28M | $24M | · | $24M | $24M | · | |
| Stock-based Comp | $9M | $9M | $8M | $8M | $9M | $7M | $8M | $7M | $8M | $7M | $7M | · | $7M | $7M | · | |
| Deferred Tax | $668.0K | $-20M | $-2M | $-725.0K | $-3M | $3M | $-2M | $-2M | $-4M | $-6M | $-3M | · | · | · | · | |
| Amort. of Intangibles | $12M | $12M | $12M | $13M | $13M | $13M | $14M | $14M | $14M | $13M | $9M | $9M | $15M | $10M | $11M | |
| Restructuring | $2M | $196.0K | $1M | $204.0K | $1M | $984.0K | $4M | $5M | $5M | $6M | $8M | $86.0K | $701.0K | $44.0K | $165.0K | |
| Operating Cash Flow | $52M | $71M | $94M | $111M | $17M | $117M | $44M | $49M | $-27M | $64M | $-540.0K | · | $80M | $64M | · | |
| CapEx | $8M | $18M | $6M | $5M | $4M | $16M | $9M | $9M | $6M | $7M | $-3M | · | $93M | $17M | · | |
| Investing Cash Flow | $-22M | $-87M | $-29M | $-30M | $-33M | $18M | $-17M | $-23M | $-139M | $-13M | $-269M | · | $-18M | $-36M | · | |
| Net Debt Issued | $-2M | · | · | · | $-2M | · | · | · | $-2M | · | · | · | · | · | · | |
| Stock Repurchased | · | $100M | $0 | · | · | $150M | $0 | · | · | $0 | $0 | · | $0 | $0 | · | |
| Financing Cash Flow | $-52M | $-101M | $2M | $-77M | $-2M | $-151M | $1M | $-75M | $334M | $-64M | $109M | · | $-2M | $-50M | · | |
| Net Change in Cash | $-22M | $-118M | $67M | $4M | $-14M | $-14M | $22M | $-45M | $166M | $-15M | $-157M | · | $60M | $-17M | · | |
| Free Cash Flow | $44M | · | · | · | $14M | · | · | · | $-33M | · | · | · | · | · | · |
수익성 8
| 지표 | 추세 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.8% | · | 59.7% | 59.5% | 59.8% | · | 55.5% | 54.2% | 52.0% | · | 52.9% | 53.6% | · | 52.0% | 53.1% | |
| Operating Margin | 16.9% | · | 19.9% | 17.9% | 16.8% | · | 16.9% | 15.0% | 11.8% | · | 13.7% | 11.1% | · | 14.2% | 15.7% | |
| Net Margin | 9.7% | · | 13.2% | 11.8% | 10.6% | · | 10.8% | 9.8% | 11.4% | · | 9.3% | 7.8% | · | 10.8% | 11.2% | |
| Pretax Margin | 14.0% | · | 17.7% | 15.7% | 14.1% | · | 14.3% | 12.9% | 13.9% | · | 13.1% | 10.3% | · | 13.8% | 13.8% | |
| EBITDA Margin | 16.9% | · | 19.9% | 17.9% | 16.8% | · | 16.9% | 15.0% | 11.8% | · | 13.7% | 11.1% | · | 14.2% | 15.7% | |
| ROA | 1.4% | · | 1.8% | 1.6% | 1.4% | · | 1.6% | 1.5% | 1.7% | · | 1.5% | 1.3% | · | 1.8% | 1.8% | |
| ROE | 3.8% | · | 4.9% | 4.5% | 3.8% | · | 4.0% | 3.8% | 4.3% | · | 3.6% | 3.1% | · | 4.4% | 4.7% | |
| ROIC | 2.0% | · | 2.4% | 2.1% | 1.9% | · | 2.1% | 1.9% | 1.5% | · | 1.8% | 1.6% | · | 2.2% | 2.4% |
유동성 및 지급능력 4
| 지표 | 추세 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | · | 1.7 | 1.6 | 1.7 | · | 4.0 | 3.5 | 3.8 | · | 2.9 | 3.3 | · | 3.1 | 2.7 | |
| Quick Ratio | 1.7 | · | 1.0 | 0.9 | 0.9 | · | 2.1 | 1.9 | 2.1 | · | 1.5 | 2.0 | · | 1.8 | 1.6 | |
| Debt / Equity | 1.4 | · | 1.3 | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 0.9 | 0.9 | · | 1.0 | 1.1 | |
| LT Debt / Equity | 1.4 | · | 1.0 | 1.1 | 1.0 | · | 1.3 | 1.4 | 1.3 | · | 0.9 | 0.8 | · | 1.0 | 1.0 |
효율성 3
| 지표 | 추세 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.2 | 0.2 | · | 0.2 | 0.2 | |
| Inventory Turnover | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.5 | · | 0.5 | 0.5 | |
| Receivables Turnover | 1.6 | · | 1.7 | 1.6 | 1.6 | · | 1.6 | 1.8 | 1.8 | · | 1.7 | 1.8 | · | 1.8 | 1.9 |
가치 평가 (TTM) 14
| 지표 | 추세 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.33B | · | $1.34B | $1.34B | $1.35B | · | $1.37B | $1.34B | $1.30B | · | $1.27B | $1.23B | · | · | · | |
| Net Income TTM | $150M | · | $155M | $144M | $144M | · | $141M | $128M | $136M | · | $130M | $132M | · | · | · | |
| Market Cap | $3.51B | · | $3.76B | $2.25B | $3.55B | · | $3.90B | $4.02B | $4.23B | · | $4.34B | $4.55B | · | $3.97B | $3.75B | |
| Enterprise Value | $4.47B | · | $4.62B | $3.18B | $4.49B | · | $4.80B | $4.95B | $5.11B | · | $5.02B | $4.96B | · | $4.51B | $4.32B | |
| P/E | 24.3 | · | 25.1 | 16.6 | 26.0 | · | 28.2 | 32.0 | 31.5 | · | 33.8 | 35.0 | · | · | · | |
| P/S | 2.6 | · | 2.8 | 1.7 | 2.6 | · | 2.9 | 3.0 | 3.3 | · | 3.4 | 3.7 | · | · | · | |
| P/B | 4.2 | · | 4.1 | 2.7 | 4.0 | · | 4.3 | 4.6 | 4.7 | · | 4.6 | 5.1 | · | 5.1 | 5.1 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | 25.6 | · | 155.7 | · | |
| P / Cash Flow | 67.2 | · | · | · | 204.3 | · | · | · | -154.3 | · | · | · | · | · | · | |
| P / FCF | 79.1 | · | · | · | 260.5 | · | · | · | -127.9 | · | · | · | · | · | · | |
| EV / EBITDA | 77.7 | · | 68.6 | 54.4 | 83.3 | · | 81.3 | 95.7 | 128.6 | · | 109.2 | 140.4 | · | 104.2 | 92.5 | |
| EV / FCF | 100.5 | · | · | · | 328.9 | · | · | · | -154.5 | · | · | · | · | · | · | |
| EV / Revenue | 3.4 | · | 3.5 | 2.4 | 3.3 | · | 3.5 | 3.7 | 3.9 | · | 3.9 | 4.0 | · | · | · | |
| Earnings Yield | 4.1% | · | 4.0% | 6.0% | 3.9% | · | 3.5% | 3.1% | 3.2% | · | 3.0% | 2.9% | · | · | · |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| 매출 | $1.33B | $1.36B | $1.31B | $1.17B | $993M |
| 매출 총이익률 % | 59.0% | 55.0% | 52.8% | 52.6% | 50.9% |
| 영업이익률 % | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% |
| 순이익 | $97M | $168M | $118M | $115M | $43M |
| 희석 EPS | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 |
대차대조표
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | 1.5 | 1.5 | 0.8 | 0.9 | 1.0 |
| 유동비율 | 3.0 | 1.6 | 2.6 | 3.1 | 1.7 |
| 당좌 비율 | 1.6 | 0.9 | 1.3 | 1.8 | 0.9 |
현금 흐름
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $260M | $142M | $115M | $163M | $76M |
최신 뉴스 이 회사 관련 최근 헤드라인
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 363개의 제출자 · $2.6B 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 62 (+3 이전 분기 대비) | 43 (-12 이전 분기 대비) | 108 (-5 이전 분기 대비) | 112 (-3 이전 분기 대비) | +1.2M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| VANGUARD GROUP INC | $349,945,961 | 4,366,138 | 13.44% | 주식 |
| NEUBERGER BERMAN GROUP LLC | $308,172,249 | 4,108,761 | 11.84% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $190,979,550 | 2,546,394 | 7.34% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $154,468,350 | 2,059,578 | 5.93% | 주식 |
| STATE STREET CORP | $136,363,950 | 1,818,186 | 5.24% | 주식 |
| CITADEL ADVISORS LLC | $113,259,000 | 1,510,120 | 4.35% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $109,143,975 | 1,455,253 | 4.19% | 주식 |
| River Road Asset Management, LLC | $96,420,150 | 1,285,602 | 3.70% | 주식 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $86,651,325 | 1,155,351 | 3.33% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $79,315,930 | 1,057,321 | 3.05% | 주식 |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $62,319,375 | 830,925 | 2.39% | 주식 |
| GOLDMAN SACHS GROUP INC | $52,644,150 | 701,922 | 2.02% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $44,356,725 | 591,423 | 1.70% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $42,780,975 | 570,413 | 1.64% | 주식 |
| Holocene Advisors, LP | $41,264,625 | 550,195 | 1.58% | 주식 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $37,034,909 | 493,796 | 1.42% | 주식 |
| North Peak Capital Management, LLC | $25,730,775 | 343,077 | 0.99% | 주식 |
| LONDON CO OF VIRGINIA | $25,543,299 | 340,574 | 0.98% | 주식 |
| DEUTSCHE BANK AG\ | $25,282,575 | 337,101 | 0.97% | 주식 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $24,905,625 | 332,075 | 0.96% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $24,779,850 | 330,398 | 0.95% | 주식 |
| Boston Trust Walden Corp | $24,170,475 | 322,273 | 0.93% | 주식 |
| Aristotle Capital Boston, LLC | $21,721,809 | 289,624 | 0.83% | 주식 |
| MIZUHO MARKETS AMERICAS LLC | $21,166,050 | 282,214 | 0.81% | 주식 |
| BANK OF AMERICA CORP /DE/ | $20,122,875 | 268,305 | 0.77% | 주식 |
| Invenomic Capital Management LP | $16,216,275 | 216,217 | 0.62% | 주식 |
| FMR LLC | $15,638,325 | 208,511 | 0.60% | 주식 |
| HEARTLAND ADVISORS INC | $15,000,000 | 200,000 | 0.58% | 주식 |
| GLENMEDE TRUST CO NA | $14,454,000 | 192,720 | 0.56% | 주식 |
| MORGAN STANLEY | $13,073,475 | 174,313 | 0.50% | 주식 |
| Longaeva Partners L.P. | $12,286,650 | 163,822 | 0.47% | 주식 |
| RHUMBLINE ADVISERS | $10,812,225 | 144,163 | 0.42% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $10,613,250 | 141,510 | 0.41% | 주식 |
| Balyasny Asset Management L.P. | $10,123,575 | 134,981 | 0.39% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $9,750,000 | 130,000 | 0.37% | 주식 |
| Point72 Asset Management, L.P. | $8,192,700 | 109,236 | 0.31% | 주식 |
| Verition Fund Management LLC | $7,913,100 | 105,508 | 0.30% | 주식 |
| ARIEL INVESTMENTS, LLC | $7,569,975 | 100,933 | 0.29% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $7,500,000 | 100,000 | 0.29% | 콜 옵션 |
| KESTREL INVESTMENT MANAGEMENT CORP | $7,305,000 | 97,400 | 0.28% | 주식 |
| Divisadero Street Capital Management, LP | $7,234,425 | 96,459 | 0.28% | 주식 |
| Swiss National Bank | $6,997,500 | 93,300 | 0.27% | 주식 |
| GOLDMAN SACHS GROUP INC | $6,750,000 | 90,000 | 0.26% | 콜 옵션 |
| GOLDMAN SACHS GROUP INC | $6,750,000 | 90,000 | 0.26% | 풋 옵션 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6,510,000 | 86,800 | 0.25% | 콜 옵션 |
| Squarepoint Ops LLC | $6,459,300 | 86,124 | 0.25% | 주식 |
| RAYMOND JAMES FINANCIAL INC | $6,215,025 | 82,867 | 0.24% | 주식 |
| Quantinno Capital Management LP | $5,477,550 | 73,034 | 0.21% | 주식 |
| ROYCE & ASSOCIATES LP | $5,360,625 | 71,475 | 0.21% | 주식 |
| AMERIPRISE FINANCIAL INC | $5,358,525 | 71,447 | 0.21% | 주식 |
| JUPITER ASSET MANAGEMENT LTD | $5,229,300 | 69,724 | 0.20% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $5,166,634 | 91,672 | 0.20% | 주식 |
| SEGALL BRYANT & HAMILL, LLC | $5,106,900 | 68,092 | 0.20% | 주식 |
| AMERICAN CAPITAL MANAGEMENT INC | $5,018,625 | 66,915 | 0.19% | 주식 |
| ISTHMUS PARTNERS, LLC | $4,946,325 | 65,951 | 0.19% | 주식 |
| Corient Private Wealth LP | $4,851,975 | 64,693 | 0.19% | 주식 |
| FIRST TRUST ADVISORS LP | $4,751,850 | 63,358 | 0.18% | 주식 |
| DEAN INVESTMENT ASSOCIATES, LLC | $4,649,175 | 61,989 | 0.18% | 주식 |
| PEREGRINE CAPITAL MANAGEMENT LLC | $4,497,450 | 59,966 | 0.17% | 주식 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $4,484,325 | 59,791 | 0.17% | 주식 |
| Bridgewater Associates, LP | $4,479,975 | 59,733 | 0.17% | 주식 |
| ENVESTNET ASSET MANAGEMENT INC | $4,181,475 | 55,753 | 0.16% | 주식 |
| Trexquant Investment LP | $3,946,425 | 52,619 | 0.15% | 주식 |
| Aequim Alternative Investments LP | $3,840,000 | 51,200 | 0.15% | 주식 |
| RICE HALL JAMES & ASSOCIATES, LLC | $3,827,850 | 51,038 | 0.15% | 주식 |
| JANE STREET GROUP, LLC | $3,682,500 | 49,100 | 0.14% | 콜 옵션 |
| MetLife Investment Management, LLC | $3,681,075 | 49,081 | 0.14% | 주식 |
| BlackRock, Inc. | $3,618,975 | 48,253 | 0.14% | 주식 |
| Retirement Systems of Alabama | $3,604,875 | 48,065 | 0.14% | 주식 |
| Riverwater Partners LLC | $3,573,375 | 47,645 | 0.14% | 주식 |
| Skylands Capital, LLC | $3,571,875 | 47,625 | 0.14% | 주식 |
| FIFTH THIRD BANCORP | $3,561,472 | 47,486 | 0.14% | 주식 |
| ALGERT GLOBAL LLC | $3,522,750 | 46,970 | 0.14% | 주식 |
| STATE OF WISCONSIN INVESTMENT BOARD | $3,441,750 | 45,890 | 0.13% | 주식 |
| Qube Research & Technologies Ltd | $3,425,475 | 45,673 | 0.13% | 주식 |
| Dean Capital Management | $3,372,600 | 44,968 | 0.13% | 주식 |
| VANGUARD ASSET MANAGEMENT, Ltd | $3,351,375 | 44,685 | 0.13% | 주식 |
| EASTERLY INVESTMENT PARTNERS LLC | $3,248,025 | 43,307 | 0.12% | 주식 |
| Phocas Financial Corp. | $3,227,250 | 43,030 | 0.12% | 주식 |
| ZB,N.A. | $3,200,968 | 40,996 | 0.12% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $3,190,200 | 42,536 | 0.12% | 주식 |
| CONNORS INVESTOR SERVICES INC | $3,150,000 | 42,000 | 0.12% | 주식 |
| Expect Equity LLC | $3,076,950 | 41,026 | 0.12% | 주식 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2,964,874 | 52,606 | 0.11% | 주식 |
| BEACON INVESTMENT ADVISORS LLC | $2,783,648 | 37,115 | 0.11% | 주식 |
| Campbell & CO Investment Adviser LLC | $2,763,300 | 36,844 | 0.11% | 주식 |
| Assenagon Asset Management S.A. | $2,633,175 | 35,109 | 0.10% | 주식 |
| BARCLAYS PLC | $2,448,300 | 32,644 | 0.09% | 주식 |
| MARSHALL WACE, LLP | $2,286,975 | 30,493 | 0.09% | 주식 |
| Cubist Systematic Strategies, LLC | $2,219,702 | 45,541 | 0.09% | 주식 |
| XTX Topco Ltd | $2,208,150 | 29,442 | 0.08% | 주식 |
| Legal & General Group Plc | $2,032,875 | 27,105 | 0.08% | 주식 |
| CARY STREET PARTNERS FINANCIAL LLC | $1,999,800 | 26,664 | 0.08% | 주식 |
| Nierenberg Investment Management Company, LLC | $1,971,000 | 26,280 | 0.08% | 주식 |
| Aurora Investment Counsel | $1,912,575 | 25,501 | 0.07% | 주식 |
| WESBANCO BANK INC | $1,912,500 | 25,500 | 0.07% | 주식 |
| Cardinal Capital Management | $1,861,275 | 24,817 | 0.07% | 주식 |
| NEW YORK STATE COMMON RETIREMENT FUND | $1,846,275 | 24,617 | 0.07% | 주식 |
| Legato Capital Management LLC | $1,758,750 | 23,450 | 0.07% | 주식 |
| CITADEL ADVISORS LLC | $1,740,000 | 23,200 | 0.07% | 콜 옵션 |
회사 내부자 72 명의 내부자 · 48 임원 · 25 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Christopher Simon, | President & CEO | 2026년 5월 15일 A | 444,704 | 0 | 0 | $0 |
| Brian Concannon | President & CEO | 2015년 9월 15일 M | 147,040 | 0 | 0 | $0 |
| James Darecca | EVP, Chief Financial Officer | 2026년 5월 15일 A | 54,444 | 0 | 0 | $0 |
| William P. Mr. Burke | EVP, Chief Financial Officer | 2021년 8월 23일 M | 30,291 | 0 | 0 | $0 |
| Christopher J Lindop | CFO & EVP Business Development | 2016년 1월 13일 A | 56,743 | 0 | 0 | $0 |
| Ronald J Ryan | VP and CFO | 2006년 11월 1일 P | 2,101 | 0 | 0 | $0 |
| Stewart W Strong | President, Global Hospital | 2024년 7월 26일 S | 18,196 | 0 | 0 | $0 |
| Byron Selman | President, Global Markets | 2016년 10월 25일 A | 23,318 | 0 | 0 | $0 |
| Peter M Allen | President, Global Plasma | 2015년 7월 6일 M | 34,102 | 0 | 0 | $0 |
| Kelly Michael P | President, Global Markets | 2013년 11월 11일 M | 10,987 | 0 | 0 | $0 |
| Mikael Gordon | President, Global Markets | 2012년 5월 3일 M | 4,442 | 0 | 0 | $0 |
| Remi Corlin | President, Asia | 2008년 8월 8일 M | 884 | 0 | 0 | $0 |
| Keiko Hattori | President, Haemonetics Japan | 2008년 5월 1일 P | 716 | 0 | 0 | $0 |
| Thomas Lawlor | President, Patient Division | 2007년 11월 28일 M | 0 | 0 | 0 | $0 |
| Ryoji Sakai | President, Japan | 2007년 6월 14일 M | 0 | 0 | 0 | $0 |
| Ulrich Eckert | President, Europe & Latin Am | 2006년 11월 1일 P | 890 | 0 | 0 | $0 |
| Yutaka Sakurada | President, Japan & Asia | 2005년 5월 2일 P | 2,347 | 0 | 0 | $0 |
| Frank Chan | EVP, Chief Operating Officer | 2026년 5월 15일 A | 32,936 | 0 | 0 | $0 |
| Kent J Davies | Chief Operating Officer | 2015년 10월 23일 S | 16,891 | 0 | 0 | $0 |
| Farris Maryanne Maunsell | VP, Chief Accounting Officer | 2026년 6월 5일 F | 6,242 | 0 | 0 | $0 |
| Laurie A. Miller | SVP, Human Resources | 2026년 6월 5일 F | 40,987 | 0 | 0 | $0 |
| Roy Galvin | EVP, Chief Commercial Officer | 2026년 5월 15일 A | 39,882 | 0 | 0 | $0 |
| Michelle L Basil | EVP and General Counsel | 2026년 5월 15일 A | 68,829 | 0 | 0 | $0 |
| Anila Lingamneni | EVP, Chief Technology Officer | 2024년 7월 12일 S | 21,331 | 0 | 0 | $0 |
| Josep Llorens | EVP, Global Manufacturing | 2024년 5월 28일 F | 30,940 | 0 | 0 | $0 |
| Dan Goldstein | VP, Corporate Controller | 2022년 6월 13일 S | 4,447 | 0 | 0 | $0 |
| Jacqueline Scanlan | SVP, Global Human Resources | 2021년 6월 7일 S | 4,216 | 0 | 0 | $0 |
| Said Bolorforosh | EVP, Chief Technology Officer | 2019년 11월 11일 S | 1,977 | 0 | 0 | $0 |
| Neil 122-62-507 Ryding | EVP, Global Manufacturing | 2018년 6월 7일 S | 15,226 | 0 | 0 | $0 |
| David Fusco | EVP, Global Human Resources | 2016년 10월 25일 A | 16,867 | 0 | 0 | $0 |
| Sandra Jesse | EVP and Chief Legal Officer | 2016년 10월 25일 A | 48,166 | 0 | 0 | $0 |
| Jonathan White | Chief Science and Technology | 2015년 10월 26일 S | 30,507 | 0 | 0 | $0 |
| Susan M Hanlon | VP Finance | 2015년 10월 26일 S | 20,464 | 0 | 0 | $0 |
| Brian R Burns | EVP, Global QA/RA | 2015년 10월 23일 S | 16,235 | 0 | 0 | $0 |
| Dave Helsel | EVP, Global Manufacturing | 2015년 4월 13일 D | 13,216 | 0 | 0 | $0 |
| Kathleen Mcdaniel | EVP Global Human Resources | 2014년 8월 28일 S | 5,013 | 0 | 0 | $0 |
| Warren Nighan JR | EVP, Global QA/RA | 2013년 7월 24일 A | 7,618 | 0 | 0 | $0 |
| Joseph J Forish | VP, Human Resources | 2013년 4월 30일 P | 17,279 | 0 | 0 | $0 |
| Phillip John Brancazio | VP, Global Manufacturing | 2011년 5월 4일 P | 3,052 | 0 | 0 | $0 |
| Alicia R Lopez | VP, Corporate Affairs | 2011년 4월 5일 D | 2,815 | 0 | 0 | $0 |
| Michael I Ruxin | VP Global Software Strategies | 2010년 11월 4일 P | 215 | 0 | 0 | $0 |
| Brad Nutter | Chairman of the Board | 2010년 7월 29일 A | 10,580 | 0 | 0 | $0 |
| Robert B Ebbeling | Vice President, Operations | 2009년 5월 1일 P | 15,849 | 0 | 0 | $0 |
| Jan Conneely | VP & GM, Arryx, Inc. | 2008년 5월 1일 P | 1,041 | 0 | 0 | $0 |
| William Granville | VP, Manufacturing | 2008년 5월 1일 P | 12,188 | 0 | 0 | $0 |
| Mark A Popovsky | VP, Corporate Medical Director | 2008년 5월 1일 P | 4,891 | 0 | 0 | $0 |
| Stephen Swenson | VP & General Mgr, Global Plasm | 2008년 5월 1일 P | 3,024 | 0 | 0 | $0 |
| William Roche Still | VP & Gen Mrg, Therapeutics Bus | 2007년 5월 4일 M | 4,193 | 0 | 0 | $0 |
| Lloyd Emerson Johnson | 이사 | 2026년 7월 24일 A | 15,471 | 0 | 0 | $0 |
| Diane M Bryant | 이사 | 2026년 7월 24일 A | 9,664 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 8 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| 미공개 보고자, 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2004년 2월 6일 | — | 최초 제출 | — | SEC |
| 미공개 보고자, 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2003년 8월 20일 | — | 최초 제출 | — | SEC |
| 미공개 보고자, 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2003년 8월 8일 | — | 최초 제출 | — | SEC |
| 미공개 보고자, 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2003년 6월 24일 | — | 최초 제출 | — | SEC |
| 미공개 보고자, 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2003년 6월 19일 | — | 최초 제출 | — | SEC |
| 미공개 보고자, 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2003년 6월 3일 | — | 최초 제출 | — | SEC |
| 미공개 보고자, 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2003년 5월 27일 | — | 최초 제출 | — | SEC |
| 미공개 보고자, 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2001년 6월 15일 | — | 최초 제출 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 88 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| NBSM · Neuberger Berman ETF Trust | 1.86% | 61,981 NS | 2026년 5월 31일 | N-PORT |
| JSML · Janus Detroit Street Trust | 0.84% | 43,927 NS | 2026년 4월 30일 | N-PORT |
| JSMD · Janus Detroit Street Trust | 0.77% | 125,093 NS | 2026년 4월 30일 | N-PORT |
| ROSC · Lattice Strategies Trust | 0.64% | 5,836 NS | 2026년 4월 30일 | N-PORT |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0.46% | 12,701 NS | 2026년 5월 31일 | N-PORT |
| PSC · Principal Exchange-Traded Funds | 0.36% | 110,180 NS | 2026년 6월 30일 | N-PORT |
| CALF · Pacer Funds Trust | 0.35% | 201,070 NS | 2026년 4월 30일 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.32% | 35,814 NS | 2026년 5월 31일 | N-PORT |
| ABCS · EA Series Trust | 0.31% | 522 NS | 2026년 5월 29일 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0.24% | 41,437 NS | 2026년 4월 30일 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.19% | 76,694 NS | 2026년 5월 31일 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.14% | 17,393 NS | 2026년 4월 30일 | N-PORT |
| MIDE · DBX ETF Trust | 0.13% | 63 NS | 2026년 5월 29일 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0.13% | 1,703 NS | 2026년 4월 30일 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0.12% | 12,097 NS | 2026년 4월 30일 | N-PORT |
| SMDX · Tidal Trust III | 0.12% | 2,419 NS | 2026년 4월 30일 | N-PORT |
| NUSC · Nushares ETF Trust | 0.11% | 23,551 NS | 2026년 4월 30일 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.11% | 42,163 NS | 2026년 4월 30일 | N-PORT |
| FNDA · SCHWAB STRATEGIC TRUST | 0.10% | 126,817 NS | 2026년 5월 31일 | N-PORT |
| EBIT · Harbor ETF Trust | 0.09% | 168 NS | 2026년 4월 30일 | N-PORT |
| RSSL · Global X Funds | 0.09% | 20,324 NS | 2026년 4월 30일 | N-PORT |
| ITWO · ProShares Trust | 0.08% | 2,210 NS | 2026년 5월 31일 | N-PORT |
| PTMC · Pacer Funds Trust | 0.08% | 5,212 NS | 2026년 4월 30일 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.07% | 159,737 NS | 2026년 4월 30일 | N-PORT |
| MVV · ProShares Trust | 0.07% | 1,606 NS | 2026년 5월 31일 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.07% | 222,776 NS | 2026년 5월 31일 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0.06% | 12,283 NS | 2026년 4월 30일 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0.06% | 770 NS | 2026년 4월 30일 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0.05% | 2,220 NS | 2026년 5월 31일 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0.05% | 1,979 NS | 2026년 5월 31일 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.05% | 3,866 NS | 2026년 4월 30일 | N-PORT |
| UMDD · ProShares Trust | 0.05% | 224 NS | 2026년 5월 31일 | N-PORT |
| UWM · ProShares Trust | 0.05% | 1,729 NS | 2026년 5월 31일 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.05% | 105,201 NS | 2026년 4월 30일 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.05% | 21,461 NS | 2026년 4월 30일 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.04% | 5,317 NS | 2026년 5월 31일 | N-PORT |
| URTY · ProShares Trust | 0.03% | 1,750 NS | 2026년 5월 31일 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0.03% | 2,270 NS | 2026년 5월 31일 | N-PORT |
| EBI · RBB Fund Trust | 0.03% | 2,598 NS | 2026년 5월 31일 | N-PORT |
| TILT · FlexShares Trust | 0.03% | 8,470 NS | 2026년 4월 30일 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.02% | 44,580 NS | 2026년 5월 31일 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.02% | 1,323 NS | 2026년 4월 30일 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.02% | 40,040 NS | 2026년 4월 30일 | N-PORT |
| HDG · ProShares Trust | 0.01% | 44 NS | 2026년 5월 31일 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 6,668 NS | 2026년 4월 30일 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.01% | 97,492 NS | 2026년 4월 30일 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.01% | 2,539 NS | 2026년 4월 30일 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0.01% | 1,282 NS | 2026년 5월 31일 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.01% | 11,534 NS | 2026년 4월 30일 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 14,005 NS | 2026년 4월 30일 | N-PORT |